2014
DOI: 10.1155/2014/976851
|View full text |Cite
|
Sign up to set email alerts
|

Topical Pimecrolimus as a New Optional Treatment in Cutaneous Sarcoidosis of Lichenoid Type

Abstract: We report the case of cutaneous sarcoidosis of lichenoid type successfully treated with pimecrolimus. For the first time in the literature, we propose the use of this topical calcineurin inhibitor for the treatment of the cases refractory to common therapy regimens.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 13 publications
0
2
0
Order By: Relevance
“…More recently, topical pimecrolimus 1% was applied after topical clobetasol failed to treat lichenoid sarcoidosis lesions on the right knee; after 12 months, the patient remained relapse-free [5].…”
Section: Case Reportmentioning
confidence: 99%
See 1 more Smart Citation
“…More recently, topical pimecrolimus 1% was applied after topical clobetasol failed to treat lichenoid sarcoidosis lesions on the right knee; after 12 months, the patient remained relapse-free [5].…”
Section: Case Reportmentioning
confidence: 99%
“…Lichenoid sarcoidosis is an extremely rare cutaneous variant of sarcoidosis, occurring in approximately 1-2% of all cutaneous presentations [1]. It is classically described in Asian children and usually affects the eyes and joints, sparing respiratory involvement [2] .However, case reports in adults and the elderly are frequent [3][4][5][6][7].…”
Section: Introductionmentioning
confidence: 99%